BLLN · NASDAQ · Medical - Diagnostics & Research

BillionToOne (BLLN)

Develops molecular diagnostics for prenatal screening and cancer treatment selection.

$115.74
vs last close−0.33 (−0.28%)

Something off on this page? Send us feedback.

Next report
Oct 6, 26
in 13 days
EPS estimate
$0.16
Revenue estimate
$116.1M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Oct '25Dec '25Mar '26May '26Aug '26Oct '26
Reported−$0.02$0.10$0.11$0.34$0.15Pending
Estimate$0.14$0.14$0.07$0.01$0.18$0.16
Surprise−114.3%−28.3%+57.1%+3,300.0%−18.2%

RevenueReportedEstimate

Oct '25Dec '25Mar '26May '26Aug '26Oct '26
Reported$66.6M$83.5M$96.1M$108.4M$109.4MPending
Estimate$82.9M$82.9M$87.2M$97.1M$109.2M$116.1M
Surprise−19.7%+0.7%+10.2%+11.6%+0.2%

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2028$0.55
Sep 2028$0.50
Jun 2028$0.41
Mar 2028$0.41
Dec 2027$0.28
Sep 2027$0.27
Jun 2027$0.23
Mar 2027$0.24
Dec 2026$0.19
Oct 2026$0.16
Aug 2026$0.18$0.15−18.2%
May 2026$0.01$0.34+3,300.0%
Mar 2026$0.07$0.11+57.1%
Dec 2025$0.14$0.10−28.3%
Oct 2025

The latest year is open to everyone — the 1 quarter behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2028$0.55$202.4M
Sep 2028$0.50$191.7M
Jun 2028$0.41$179.8M
Mar 2028$0.41$167.3M
Dec 2027$0.28$155.0M
Sep 2027$0.27$148.7M
Jun 2027$0.23$139.9M
Mar 2027$0.24$131.1M
Dec 2026$0.19$121.9M
Oct 6, 2026$0.16$116.1M
Aug 5, 2026$0.18$0.15−18.2%$109.2M$109.4M+0.2%−38.9%
May 6, 2026$0.01$0.34+3,300.0%$97.1M$108.4M+11.6%+14.1%
Mar 4, 2026$0.07$0.11+57.1%$87.2M$96.1M+10.2%−10.7%
Dec 9, 2025$0.14$0.10−28.3%$82.9M$83.5M+0.7%−5.3%
Oct 7, 2025

The latest year is open to everyone — the 1 quarter behind it read with an account.